European regulation on clinical trials for medicinal products: The end of the transition period
https://ansm.sante.fr/actualites/reglement-europeen-relatif-aux-essais-cliniques-de-medicaments-fin-de-la-periode-de-transition
The ANSM publishes its haemovigilance report for 2023
https://ansm.sante.fr/actualites/lansm-publie-son-rapport-dhemovigilance-de-lannee-2023
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 October 2024
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-31-october-2024
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 October 2024
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-october-2024
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 September-3 October 2024
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-30-september-3-october-2024
